These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Dimoulios P; Vardas E; Roussomoustakaki M; Maniatis AN; Kouroumalis EA Int J Colorectal Dis; 2003 May; 18(3):254-9. PubMed ID: 12673492 [TBL] [Abstract][Full Text] [Related]
5. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Kronborg G; Ostergaard C; Weis N; Nielsen H; Obel N; Pedersen SS; Price PA; Johansen JS Scand J Infect Dis; 2002; 34(5):323-6. PubMed ID: 12069012 [TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 levels in patients with coronary artery disease. Kucur M; Isman FK; Karadag B; Vural VA; Tavsanoglu S Coron Artery Dis; 2007 Aug; 18(5):391-6. PubMed ID: 17627189 [TBL] [Abstract][Full Text] [Related]
7. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595 [TBL] [Abstract][Full Text] [Related]
8. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Høgdall EV; Johansen JS; Kjaer SK; Price PA; Christensen L; Blaakaer J; Bock JE; Glud E; Høgdall CK Oncol Rep; 2003; 10(5):1535-8. PubMed ID: 12883737 [TBL] [Abstract][Full Text] [Related]
9. Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Tran A; Benzaken S; Saint-Paul MC; Guzman-Granier E; Hastier P; Pradier C; Barjoan EM; Demuth N; Longo F; Rampal P Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):989-93. PubMed ID: 11007134 [TBL] [Abstract][Full Text] [Related]
10. [Observations on the increased serum levels of YKL-40 in patients with rheumatoid arthritis and osteoarthritis]. Morgante M; Metelli MR; Morgante D Minerva Med; 2001 Jun; 92(3):151-3. PubMed ID: 11404723 [TBL] [Abstract][Full Text] [Related]
11. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743 [TBL] [Abstract][Full Text] [Related]
12. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Roslind A; Johansen JS Methods Mol Biol; 2009; 511():159-84. PubMed ID: 19347297 [TBL] [Abstract][Full Text] [Related]
13. Plasma YKL-40, a new biomarker for atrial fibrillation? Henningsen KM; Therkelsen SK; Johansen JS; Bruunsgaard H; Svendsen JH Europace; 2009 Aug; 11(8):1032-6. PubMed ID: 19411674 [TBL] [Abstract][Full Text] [Related]
14. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792 [TBL] [Abstract][Full Text] [Related]
15. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: preliminary results. Kaynar MY; Tanriverdi T; Kafadar AM; Kacira T; Yurdakul F; Uzun H; Gumustas K J Clin Neurosci; 2005 Sep; 12(7):754-7. PubMed ID: 16153848 [TBL] [Abstract][Full Text] [Related]
16. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010 [TBL] [Abstract][Full Text] [Related]